Leukocyte filtration has evolved as an important technique in cardiac surge
ry with cardiopulmonary bypass to prevent pathogenic effector functions med
iated by activated leukocytes. The underlying mechanisms that result in an
improvement of laboratory variables as well as clinical outcome are not res
olved yet. Moreover, the optimum strategy for the use of current filtration
technology has not been systematically evaluated. This paper, therefore, r
eviews how activated leukocytes may lead to tissue damage, summarizes the k
nown effects of leukocyte filtration on clinical outcome and laboratory par
ameters, and deals with current experimental and clinical efforts to furthe
r limit the pathogenic effects of leukocytes in cardiac surgery,